Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Manufacturingchemist

Published November 13, 2026 · Updated November 14, 2026

The future of psychedelic drug design in mental health treatment - Manufacturing Chemist

Read the full story at Manufacturingchemist

Research is currently looking at ketamine as well as other psychedelic and psychedelic ... Octane Biotech and Currus Biologics automate CUR-001 CAR T-.

Surfaced by this Google Alert

  • Psychedelic biotech